Mirum Pharmaceuticals
MIRM
$24.46
Share price
-0.12%
Change (1 day)
-7.45%
Change (1 year)
Categories
P/S ratio for Mirum Pharmaceuticals (MIRM)
P/S ratio as of April 2024 (TTM): 6.18
According to Mirum Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.18136. At the end of 2023 the company had a P/S ratio of 7.38.
P/S ratio history for Mirum Pharmaceuticals from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.38 | -20.86% |
| 2022 | 9.33 | -63.46% |
| 2021 | 25.5 | |
| 2020 | N/A | |
| 2019 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |